Profil
Peter Pechan worked as a Vice President-Gene Therapy at LogicBio Therapeutics, Inc. in 2021.
Prior to this, he obtained a doctorate degree from Eberhard Karls Universität Tübingen.
Anciens postes connus de Peter Pechan
| Sociétés | Poste | Fin |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2021 |
Formation de Peter Pechan
| Eberhard Karls Universität Tübingen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |